Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by JJKali043on May 07, 2020 11:15am
407 Views
Post# 30997830

RE:Update from IR

RE:Update from IRSo this is the response I received from the CFO of MedMira. Typical answer, as they can't answer or disclose priviledged information however I was pleased to the the portion highlighted. Good news coming (fingers crossed). GLTA

Dear Mr. *******,
 
With regard to your questions, as you know we cannot disclose any forward looking statements, provide any expectations or indirectly provide any financial (forward looking) details. I understand this is frustrating but we are under very scrutiny by the regulators (stock exchange) and especially now during this time. We will provide all details to the public when we are allowed to by the regulators. Certainly, we are eager to inform our investors as quickly as possible but we need to adhere to the applicable regulations (the joy of being a public listed company).
 
 
Yours sincerely,
 
Markus Meile
 

Bullboard Posts